[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-PCVX":3,"homepage-market-summary":31,"stock-news-PCVX":173},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"PCVX","2026-10-07",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Vaxcyte, Inc. Common Stock","Nasdaq",null,"BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)","Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.","507","San Carlos, CA",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},66.96,65.86,67.15,64.27,66.7,0.26,0.39,11528622.409162,97580,65.9947,90.75,39.87,1537113.3215006215,53.2,1588,{"status":32,"indices":33,"watchlist":76,"sectors":98,"benchmarks":153},"success",[34,41,48,55,61,68],{"symbol":35,"name":36,"price":37,"change":38,"pct_change":39,"is_up":14,"sparkline":40,"date":5},"SPX","S&P 500",7801.77,-17.16,-0.22,"0.0,13.9 2.3,10.5 4.6,12.4 6.9,14.2 9.3,16.0 11.6,11.5 13.9,10.8 16.2,4.8 18.5,4.8 20.8,7.9 23.2,8.0 25.5,6.0 27.8,9.1 30.1,9.8 32.4,10.8 34.7,10.0 37.1,7.0 39.4,4.4 41.7,2.0 44.0,2.9",{"symbol":42,"name":43,"price":44,"change":45,"pct_change":46,"is_up":14,"sparkline":47,"date":5},"NDX","NASDAQ 100",31160.08,-64.4,-0.21,"0.0,15.0 2.3,13.4 4.6,14.8 6.9,16.0 9.3,16.0 11.6,12.9 13.9,11.7 16.2,6.5 18.5,5.0 20.8,6.6 23.2,6.6 25.5,5.8 27.8,7.8 30.1,7.4 32.4,7.0 34.7,6.4 37.1,4.6 39.4,2.9 41.7,2.0 44.0,2.4",{"symbol":49,"name":50,"price":51,"change":52,"pct_change":53,"is_up":14,"sparkline":54,"date":5},"DJI","DOW JONES",51180,-341,-0.66,"0.0,6.3 2.3,2.0 4.6,3.3 6.9,6.0 9.3,11.3 11.6,8.7 13.9,9.5 16.2,6.4 18.5,8.0 20.8,10.9 23.2,12.3 25.5,8.2 27.8,11.2 30.1,12.3 32.4,16.0 34.7,15.8 37.1,13.7 39.4,13.0 41.7,10.8 44.0,13.7",{"symbol":56,"name":57,"price":58,"change":59,"pct_change":39,"is_up":14,"sparkline":60,"date":5},"COMP","NASDAQ Composite",27538.69,-61.2,"0.0,15.1 2.3,12.9 4.6,14.2 6.9,16.0 9.3,16.0 11.6,12.2 13.9,11.3 16.2,6.1 18.5,5.1 20.8,7.7 23.2,7.7 25.5,6.6 27.8,8.7 30.1,8.9 32.4,8.4 34.7,8.3 37.1,5.5 39.4,3.1 41.7,2.0 44.0,2.5",{"symbol":62,"name":63,"price":64,"change":65,"pct_change":66,"is_up":14,"sparkline":67,"date":5},"RUT","RUSSELL 2000",2777,-36.4,-1.29,"0.0,3.5 2.3,2.0 4.6,4.2 6.9,6.7 9.3,8.2 11.6,6.3 13.9,8.0 16.2,6.1 18.5,4.1 20.8,10.7 23.2,11.0 25.5,10.7 27.8,13.1 30.1,14.4 32.4,15.8 34.7,14.3 37.1,11.2 39.4,8.9 41.7,11.4 44.0,16.0",{"symbol":69,"name":70,"price":71,"change":72,"pct_change":73,"is_up":74,"sparkline":75,"date":5},"VIX","CBOE VIX",15.08,0.07,0.47,true,"0.0,2.0 2.3,9.7 4.6,4.9 6.9,4.5 9.3,2.5 11.6,11.3 13.9,13.7 16.2,13.5 18.5,16.0 20.8,12.3 23.2,10.4 25.5,13.5 27.8,8.8 30.1,8.9 32.4,7.8 34.7,7.6 37.1,11.8 39.4,10.9 41.7,12.9 44.0,12.6",[77,84,91],{"symbol":78,"name":79,"price":80,"change":81,"pct_change":82,"is_up":14,"sparkline":83,"date":5},"NVDA","NVIDIA Corp",237.36,-1.88,-0.79,"0.0,16.0 7.3,14.6 14.7,11.8 22.0,8.2 29.3,2.4 36.7,2.0 44.0,4.2",{"symbol":85,"name":86,"price":87,"change":88,"pct_change":89,"is_up":74,"sparkline":90,"date":5},"AAPL","Apple Inc",336.67,3.04,0.91,"0.0,16.0 7.3,9.0 14.7,14.2 22.0,7.7 29.3,9.3 36.7,7.9 44.0,2.0",{"symbol":92,"name":93,"price":94,"change":95,"pct_change":96,"is_up":14,"sparkline":97,"date":5},"TSLA","Tesla Inc",377.75,-2.93,-0.77,"0.0,16.0 7.3,15.0 14.7,15.4 22.0,7.1 29.3,3.0 36.7,2.0 44.0,3.5",[99,104,109,114,119,124,129,134,139,143,148],{"name":100,"etf":101,"change":102,"price":103,"is_up":14},"Technology","XLK",-0.3,201.39,{"name":105,"etf":106,"change":107,"price":108,"is_up":14},"Financials","XLF",-0.48,53.75,{"name":110,"etf":111,"change":112,"price":113,"is_up":74},"Healthcare","XLV",1.03,168.81,{"name":115,"etf":116,"change":117,"price":118,"is_up":14},"Consumer Cycl","XLY",-0.32,111.36,{"name":120,"etf":121,"change":122,"price":123,"is_up":14},"Consumer Staples","XLP",-0.12,81.7,{"name":125,"etf":126,"change":127,"price":128,"is_up":14},"Energy","XLE",-0.58,63.38,{"name":130,"etf":131,"change":132,"price":133,"is_up":14},"Industrials","XLI",-2.18,167.84,{"name":135,"etf":136,"change":137,"price":138,"is_up":14},"Materials","XLB",-1.51,48.98,{"name":140,"etf":141,"change":66,"price":142,"is_up":14},"Real Estate","XLRE",40.57,{"name":144,"etf":145,"change":146,"price":147,"is_up":14},"Utilities","XLU",-0.02,41.15,{"name":149,"etf":150,"change":151,"price":152,"is_up":14},"Comm Services","XLC",-0.35,111.26,[154,159,164,169],{"ticker":155,"name":156,"price":157,"change":158,"is_up":14},"SPY","SPDR S&P 500 ETF",777.22,-0.24,{"ticker":160,"name":161,"price":162,"change":163,"is_up":14},"QQQ","Invesco QQQ Trust",757.73,-0.25,{"ticker":165,"name":166,"price":167,"change":168,"is_up":14},"DIA","SPDR Dow Jones ETF",511.02,-0.69,{"ticker":170,"name":171,"price":172,"change":66,"is_up":14},"IWM","iShares Russell 2000",277.7,{"ticker":4,"count":174,"articles":175},20,[176,182,188,194,200,206,212,218,224,230,236,242,248,253,258,263,268,273,277,282],{"title":177,"link":178,"pubDate":179,"description":180,"source":181},"Vaxcyte Shares Rise 50% After VAX-31 Meets Primary Endpoints in Phase 3 Trial - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMikAFBVV95cUxQWGprWE1UMmF3VHVxNm9wS2pjaVRCQ0ZpMGhlVThGWTVNQlp2dHhJZ3FOYk5WNVFnZEpDS2M3SXZ3bHV0eF84NTZ5NndpcEZtSmFiTWdpZVVod0RnWUkxNExKZ2ZNUE9sODN5M1MwZy1hUVVNandzeVdQWk5CNnVlUEE4T1VDeEFvS2V5WlBDRjY?oc=5","Mon, 05 Oct 2026 12:10:12 GMT","Vaxcyte Shares Rise 50% After VAX-31 Meets Primary Endpoints in Phase 3 Trial Yahoo Finance","Yahoo Finance",{"title":183,"link":184,"pubDate":185,"description":186,"source":187},"PCVX Stock Jumps As Traders Brace For OPUS-1 Catalyst - Timothy Sykes","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMidkFVX3lxTE5tcm1wSEFUaWRLQ21fd08tT2xldGhPeTZnUW5uSkhIeUNNU0piQnVlbklUSENYbE12d3dtaWpKNkQxcXhCSUcxbkpmb1p5N1VFQkpHeVFLOFdrRl9SVE9hRGFoc0dEek9ld00tRXpiOW53MHk2cUE?oc=5","Mon, 05 Oct 2026 11:48:00 GMT","PCVX Stock Jumps As Traders Brace For OPUS-1 Catalyst Timothy Sykes","Timothy Sykes",{"title":189,"link":190,"pubDate":191,"description":192,"source":193},"Stocks making the biggest moves midday: Microsoft, SpaceX, Vaxcyte, Banco Bradesco, DraftKings & more - CNBC","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMioAFBVV95cUxObW1JQVhXOHZ4WmVqNk1JeXdLOFZJOGtjVnVfYVhSRHIxN3dORGI4WGVjTDB3VHJHbnNBcGhvYTZ3bDNDM1hGUUNUbVd4U2VhdV96eWJYVmtvbGpkRGdIUUt5ZjY5OWR1Si0zdzRDT0hXeEo0LTA5cEN0MUtacWVrMWNGMm05bzZaTHNKSFdBem9EZThYd013TUdRVzBCRnhS?oc=5","Mon, 05 Oct 2026 17:13:38 GMT","Stocks making the biggest moves midday: Microsoft, SpaceX, Vaxcyte, Banco Bradesco, DraftKings & more CNBC","CNBC",{"title":195,"link":196,"pubDate":197,"description":198,"source":199},"Guggenheim raises Vaxcyte stock price target on vaccine trial win - Investing.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwwFBVV95cUxQeGV5bThlbV9hbFJfSWFpX2l6SEs3cDQ3MmRlZVJnNGtkNVQ2cVlUVVg5WW5OSGZ5OHFzWXpBdFI2RDF1S2hELWhhckY2MVQxNmJ3ZEFud3hXeTI0VHhnd2w5TkhJNTg3OGJpVUNiYi1WWkFRdzJrOElZYWVmTTZ0QkdzQllfazRqbGlWbE50d3RJMWNTZ19QMzg3UHVJa0dWbWdJQV9mS1FmMDVfclpTYjJ2NDFBazVMMl9CR19GRWJMZUU?oc=5","Mon, 05 Oct 2026 11:32:24 GMT","Guggenheim raises Vaxcyte stock price target on vaccine trial win Investing.com","Investing.com",{"title":201,"link":202,"pubDate":203,"description":204,"source":205},"Small Biotech Squares Up To Pfizer, Merck In $7 Billion Market - Investor's Business Daily","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMilAFBVV95cUxNNFBEVU83SWZFZ0VNcnM3SFNXZTB1WFF6MEZWN3hVcVZYZkpQUXhIQWFjSWpYM1MwenRiLTJUUW1SNHpUMFlkUkdvVzVtMmxuSHRkN3pGX0JPbnJDZVZYV001NDBKaU1HSjZHRXNzem5yMkJBdjRoaGlNQWlKUlRIdWlhYkxuaXhfbTFnN2FnVEYzUUFv?oc=5","Mon, 05 Oct 2026 13:59:00 GMT","Small Biotech Squares Up To Pfizer, Merck In $7 Billion Market Investor's Business Daily","Investor's Business Daily",{"title":207,"link":208,"pubDate":209,"description":210,"source":211},"Two proposed $500 million offerings could fund Vaxcyte vaccine trials and U.S. launch preparations. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuAFBVV95cUxQN1lZVVNRMUpIX2s3WXh4WV9tZzdUVmhKeE1sSzMxRVhMbUxZem01UHdjX2hHQmlFTHphdXJkQmpFb0RnTU85R1hfRGgtaXREdV8xWTlVVTZNaUZHNWM4OU9GRHpub3U2ak5zODltUDJGdk5tZ1lxanJnQjRVSEM1Mk5NR0szR2YwNmNQTHFGdFEyWHZCYnZRbUtpQzI1Ti1uS1ZJU1g0UThMZkxnY04tdGRTTUcxNmxW?oc=5","Tue, 06 Oct 2026 03:25:05 GMT","Two proposed $500 million offerings could fund Vaxcyte vaccine trials and U.S. launch preparations. Stock Titan","Stock Titan",{"title":213,"link":214,"pubDate":215,"description":216,"source":217},"PCVX Stock Hits Fresh 52-Week High On Late-Stage Win In Adult Pneumonia Vaccine Race: Jefferies Says It Hit ‘Blue-Sky’ Case - Stocktwits","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMikgJBVV95cUxQRXlyZU9NNmlkS1VCV1Z0T2ZURVNNeVNOTTNBVFdzWW40a0daVHpzeWtlUzQxUk1ZVDA5SUdubXNHQm1kYmUzdEpQRmxlYUNCOGFPNkx4RUh1dWc5clgzaDRLTFdueTJ3WFZ5c3B6SmNEWDFMc09jWGlIT05qVTkzWnhja2Q1dXZ1VEE4czdHOHhsTmZJQ09JTjYwY3NkUjBHOWhHQ1BiRHlic3ZuTC1HeG1vdGFnQzhRbFpjZkVfSUlmV3lQTVBPQmFWUFRGMmxnSG1kR29zcmhGUVpueXZPTjl0S3pfTXh1NmQxNGE3aGxIQ2hZajVwQmswQ3dRQURqcW9ubVdHdHhOd2hFbDNXQmlB?oc=5","Mon, 05 Oct 2026 16:24:20 GMT","PCVX Stock Hits Fresh 52-Week High On Late-Stage Win In Adult Pneumonia Vaccine Race: Jefferies Says It Hit ‘Blue-Sky’ Case Stocktwits","Stocktwits",{"title":219,"link":220,"pubDate":221,"description":222,"source":223},"Vaxcyte Stock Hits New 52-Week High - Here’s Why - Vaxcyte (NASDAQ:PCVX) - Benzinga","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipAFBVV95cUxQTm1yUTBSb2pDek9GNWk0cnh4LW5LazM0RmJsVFNQeGp0SnpfQzFqbWp3amxaeEFVRldzZV82bXoyZVRiSEI0N0xEajdTSno1MDJKeUpLMjVzdnZXMUJpOE5NMF9kTC16VHJZVGwyWmRNUlk1OE9KeWJzc0szYk13MHk5NGczelZzb1VtYjFPLWltcnlrZThmWE45WFkzcTVWOVFUMw?oc=5","Mon, 05 Oct 2026 12:55:17 GMT","Vaxcyte Stock Hits New 52-Week High - Here’s Why - Vaxcyte (NASDAQ:PCVX) Benzinga","Benzinga",{"title":225,"link":226,"pubDate":227,"description":228,"source":229},"Vaxcyte Stock Spikes 27% as Lead Vaccine Candidate Takes Aim at Pfizer and Merck - Barron's","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiggFBVV95cUxQMU8yUzk3OVpkcEpCRXk0OHd3bmRIR1B3LVMzUnE3TW1mT252d2dCOU85TXJJdXRUSFBqckRnNXgwdlVOMEloVFkyTU9NdDBZWkhkN0ExTWVZcWpoYkQzSVBZcjZmb3VLQ3VZalN5R1dMMWZmS3ZlVkQyQUxZdEk2RjZB?oc=5","Mon, 05 Oct 2026 16:52:00 GMT","Vaxcyte Stock Spikes 27% as Lead Vaccine Candidate Takes Aim at Pfizer and Merck Barron's","Barron's",{"title":231,"link":232,"pubDate":233,"description":234,"source":235},"PCVX Stock Jumps As Traders Brace For OPUS-1 Catalyst - StocksToTrade","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMidEFVX3lxTE5iODZOdEItaU9OeUdicjl3U2hPQ1pYWEdMazh1Y3NyLXZQRFF3eVBnWG5PX29EcVMwb3c3ZGRyVTQ1dmpoTHd0aHZHc2dvc0hGVFN3VUZKTGcxMHM0TDVmOFNIWDBBV1dzUlRSeTlOLWdZck5n?oc=5","Mon, 05 Oct 2026 16:34:00 GMT","PCVX Stock Jumps As Traders Brace For OPUS-1 Catalyst StocksToTrade","StocksToTrade",{"title":237,"link":238,"pubDate":239,"description":240,"source":241},"Vaxcyte Surges on Positive Phase 3 VAX-31 Trial Readout - Quiver Quantitative","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMikgFBVV95cUxPNlo1TTQ4RUlRX0NnajFwZFM0VUw1U3ZMUnhGSzdhVUpWUFZ6a3h5dWt0VDZ3WkdpUFFfNWY5VFQwejJ1MmdTTEVhZ19MMjE2cmpreGlteDI1cHlhTU1jOGJ4b0lXbG1CUnFQcWtqMW1PRF9TS3Y0QnV3YTh4R1dYbF9fZHkwU3dvZFFtMlpaNFVVQQ?oc=5","Mon, 05 Oct 2026 14:51:00 GMT","Vaxcyte Surges on Positive Phase 3 VAX-31 Trial Readout Quiver Quantitative","Quiver Quantitative",{"title":243,"link":244,"pubDate":245,"description":246,"source":247},"Vaxcyte, Inc. - Common Stock (Nasdaq:PCVX) Stock Quote - FinancialContent","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiaEFVX3lxTE4xYVdJNmRQWXBsNGVWdDc4ZDh3andGbno4aG9JRV8yMFFKT0IydmxNUjIyMVpjUFVNdFh2VnQtb2w4dWwzTTFUei01MkEwNWp3TGJtaEhxWklGdHZQNkNPMzd4SXowT2Q3?oc=5","Mon, 05 Oct 2026 20:15:00 GMT","Vaxcyte, Inc. - Common Stock (Nasdaq:PCVX) Stock Quote FinancialContent","FinancialContent",{"title":249,"link":250,"pubDate":251,"description":252,"source":211},"About $500 million is expected from stock and $500 million from bonds. Vaxcyte plans to fund vaccine work. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivgFBVV95cUxPMlFSNE52Sy1ZTC1oTGJvVmYwd3dwRlVLdHBoOVBieDF3NVVqVVN4TTl6QVBOellFRzBURE5mYWthNExQMEp4Qllmc3BycGUtb3Q3cF93bmNfM3YtSmE2emhQSkRjRHA5QjNMdmo0Q2g1ME5kcy0yMDNuT2JnNElxTElvcUcyamE3aEtrNTZvZzJPU3F3V0NFYjRDckxTaFdVZlA1UXdBMVhHQVpUeHhVcU5sMDZNZlVVUENCNFlR?oc=5","Wed, 07 Oct 2026 08:10:11 GMT","About $500 million is expected from stock and $500 million from bonds. Vaxcyte plans to fund vaccine work. Stock Titan",{"title":254,"link":255,"pubDate":256,"description":257,"source":187},"PCVX Stock Builds Tension Ahead Of Key OPUS-1 Data - Timothy Sykes","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMieEFVX3lxTFBVbWg1SC1Gakp1b2x5eTBJOF8zOUJES2JjUEFtU3AteVVMSzVWUWFGZHNIcnd5SlBEZlFFQjIzaV9oeDFuQU1fOGRMOHRzbUt6ZnJxQWs4NDVtVlJjUTFfRmIyQVF0Y1JuNDJFdVhWUUZsUU9qUG1YdA?oc=5","Mon, 05 Oct 2026 13:18:00 GMT","PCVX Stock Builds Tension Ahead Of Key OPUS-1 Data Timothy Sykes",{"title":259,"link":260,"pubDate":261,"description":262,"source":235},"Vaxcyte PCVX Stock Heats Up Ahead OPUS-1 Data - StocksToTrade","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMidEFVX3lxTE1IejVDbmxoZ0hBcHpVOWJQb0o4MnU3VGdRbklJSnluaVE2VkR0b3FLX29KbE5PeEgyZFZ6T2taaE4wU25WZkgwR0VTVGFNQmxsR3NyeXZ1WHpJcDBHN245N0RQQzc5dXF1RWQyRHJmVVFFdUo1?oc=5","Mon, 05 Oct 2026 12:33:00 GMT","Vaxcyte PCVX Stock Heats Up Ahead OPUS-1 Data StocksToTrade",{"title":264,"link":265,"pubDate":266,"description":267,"source":181},"Vaxcyte shares surge on late-stage vaccine trial success - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMimwFBVV95cUxPYU1OMDBrSGd0cWN5SDdTNDNjLWxuRFJJbkxqOWg4NWszdnRiLUVkcGtwWW1zNWE5RVUwd2RSV0w3TmVibm1fZWRPV2VBMWdhc2JhTndBeW9zZ1NSUjhJVFY1MkhRR0Z5RWZWc29zeGM3OFVEQVBJNTlOY1RmbDVia3l5dGNBTWpoX3VuQ2daMUNiWDJlV080Uk9xMA?oc=5","Mon, 05 Oct 2026 14:32:00 GMT","Vaxcyte shares surge on late-stage vaccine trial success Yahoo Finance",{"title":269,"link":270,"pubDate":271,"description":272,"source":211},"An officer proposes selling Vaxcyte (PCVX) shares acquired by exercising stock options for cash. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMikgFBVV95cUxNdXlqcldPeFJDMkIyOTRMUklMRlZnb3hsdWo1aGZYZEFxMjFqYi0wd3lpVU1BcnU0MUdzV2NtUXJfRlNuWXNfc29JVGcyLS1HaEQyRGpyZHpobnlLSU05c1FCcDB5R01qUDRSOFdxaUlZZkpTZ09hOWowVWttcXFQTXNya3I3SXdoTGdFalRpaUc4Zw?oc=5","Mon, 05 Oct 2026 20:10:17 GMT","An officer proposes selling Vaxcyte (PCVX) shares acquired by exercising stock options for cash. Stock Titan",{"title":274,"link":275,"pubDate":185,"description":276,"source":235},"PCVX Stock Heats Up As OPUS-1 Catalyst Looms Large - StocksToTrade","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMickFVX3lxTE8xOXh6TTNxSEVIMlpGYXl2TzIwMjVtU0poOHRfaU8zVC03dC0xQkxRU0NBRm5KMzVHeU9RSE13TVJ1YXV3SEpQQ0QyNFVxNmhSN1FhSW1xSzdrekRBeG1fSmMzLWQyUnpZSW9TLVhueENhQQ?oc=5","PCVX Stock Heats Up As OPUS-1 Catalyst Looms Large StocksToTrade",{"title":278,"link":279,"pubDate":280,"description":281,"source":211},"Trial data on a vaccine designed to prevent bacterial pneumonia are set for Oct. 5. Vaxcyte will present them. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivwFBVV95cUxQaDh4b1ItYmJmSU9yR3BqYTVlWHJWTG5PUjZFMEVmSDRVejFFVjQ3RXI4dVdOaldvcWNTSkdBZHFXamN6SW50cmNzUUFmcFNkUGRUU2dTU1RuWEl0UXNxaGpBTzRMZ1VsaUJOcFQzNVpiQkRZYjc4YnBwRF9KU1ZFc1RVak01RW9jZXNaYm05MGE5ZjNOam9faG81Z0wydURsWGtZNWF2YUJRUHkzbjNfcl9UU3lhWXJkeHVfR3NXQQ?oc=5","Mon, 05 Oct 2026 08:51:35 GMT","Trial data on a vaccine designed to prevent bacterial pneumonia are set for Oct. 5. Vaxcyte will present them. Stock Titan",{"title":283,"link":284,"pubDate":285,"description":286,"source":199},"Vaxcyte stock falls on $1B dual offering launch - Investing.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipgFBVV95cUxPY1JHNDVWTVpOOEVyYjZBMk5LSUFNZE0tYzIxTTdxY0p0OHFXNlJFUmVTUkVkVzhscXdRTVljSDI2ZFhGQWFnMlBvVldhMi1ESUJIMjV2Yy1IdGpoMDZ0UUNEb3lMVVdZZ29BaHZiRWFmTm5mYUg2S0NSUkFvMU9nM19LZ1ZuRHhKM193WnNKY3pzOHFmRFUyeUJtU2VNcUFtRG5JdHVn?oc=5","Mon, 05 Oct 2026 20:58:57 GMT","Vaxcyte stock falls on $1B dual offering launch Investing.com"]